查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1777647

全球尿道感染檢測市場

Urinary Tract Infection Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 300 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球尿道感染檢測市場規模將達 7.237 億美元

全球尿道感染檢測市場規模預計在2024年為6.125億美元，預計到2030年將達到7.237億美元，在2024-2030年的分析期內，複合年成長率為2.8%。尿道炎是本報告分析的細分市場之一，預計其複合年成長率為2.1%，到分析期結束時規模將達到3.9億美元。膀胱炎細分市場在分析期間內的複合年成長率預計為3.9%。

美國市場規模估計為 1.669 億美元，中國市場預計複合年成長率為 5.2%

預計到2024年，美國尿道感染檢測市場規模將達1.669億美元。作為世界第二大經濟體，中國市場規模預計將在2030年達到1.396億美元，2024年至2030年的複合年成長率為5.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為1.1%和2.1%。在歐洲，預計德國的複合年成長率為1.6%。

全球尿道感染（UTI）檢測市場－主要趨勢與促進因素摘要

全球尿道感染負擔日益加重，導致診斷需求激增

尿道感染(UTI) 是全球最常見的細菌感染疾病之一，每年影響數億人，導致診斷檢測需求顯著增加。各年齡層尿道結石發生率不斷上升，尤其是在女性、老年人以及糖尿病、腎臟病或免疫力缺乏人群中，這推動了對快速、準確檢測解決方案的持續需求。隨著早期診斷和抗生素管理意識的不斷增強，醫療保健系統正在增加對照護現場的投資，以減輕醫院負擔並最大限度地減少抗生素的過度處方。尿道結石復發和併發症通常與導尿管使用和尿路結構性異常有關，這導致住院和門診診斷程序數量增加。此外，全球範圍內，尤其是在長期照護機構中，醫院相關感染疾病(HAI) 的增多，推動了對可靠尿道結石篩檢通訊協定的需求。隨著臨床醫生努力區分無症狀性菌尿和真正的感染疾病，需求正轉向更特異性、更靈敏的檢測，以準確指導治療決策。這種不斷發展的臨床情況正在鼓勵診斷實驗室、初級保健提供者和緊急護理中心擴大其尿道結石檢測能力，從而推動全球尿道結石檢測市場的成長。

技術進步和即時診斷如何改變尿道結石檢測？

技術創新，加上對速度、準確性和可及性的日益重視，正在顯著改變尿道感染感染檢測的模式。傳統的培養為基礎的方法雖然高度可靠，但需要24-48小時才能獲得結果，並且逐漸被快速診斷方法補充或取代。現代尿液試紙檢測和尿液檢查套件可以快速檢測亞硝酸鹽、白血球酯酶和其他重要的感染指標，使其成為急診和基層醫療機構的寶貴工具。此外，分子診斷技術，尤其是基於PCR的檢測，能夠快速識別特定病原體和抗藥性基因，顯著提高診斷準確性並支持合理的抗生素處方。即時診斷（POC）平台因其便攜性、易用性和即時提供結果的能力，正變得越來越流行，尤其是在農村和資源匱乏的地區。自動化尿液分析儀也被整合到臨床實驗室中，以簡化工作流程、減少人工錯誤並實現高通量檢測。此外，智慧型手機連接設備和人工智慧主導的診斷工具正在成為家庭尿道結石監測的新解決方案，尤其是對於患有感染疾病或性行為感染的患者。這些技術進步不僅可以提高診斷的準確性，還能幫助臨床醫師轉向實證、個人化的治療策略，最終減輕抗生素抗藥性和復發性感染疾病的負擔。

醫療保健模式和消費行為的改變是否會擴大尿道結石檢測市場？

隨著醫療保健系統朝向以患者為中心的分散式照護發展，尿道感染檢測擴大在非傳統環境中進行，包括零售診所、家用檢測場所和遠端醫療主導的診斷平台。現今的消費者要求便利性、速度和保密性，尤其是對於尿道結石這樣敏感的疾病。這導致家用尿道結石檢測套組的激增，這些試劑盒可在櫃檯或網上購買，提供隱私和快速的自我篩檢。這些套件通常使用比色試紙技術或應用程式連接的感測器，幫助使用者準確解釋結果並確定何時就醫。遠端醫療提供者也將尿道結石檢測作為備受追捧的服務，通常根據症狀和測試確認開出抗生素，而無需親自就診。此外，雇主和大學正在提供尿道結石篩檢服務作為其職業健康和保健計劃的一部分，進一步將檢測擴展到傳統臨床環境之外。在醫療保健方面，醫院、療養院和復健中心對早期發現和感染控制的重視，正在推動定期篩檢和導尿後監測。護理機構的擴張，以及患者在醫療保健中的參與度不斷提高，正在推動尿道結石檢測市場蓬勃發展且快速多樣化，並刺激了新的檢測方式和分銷模式的開發以滿足這一需求。

是什麼推動了全球尿道感染檢測市場的成長？

尿道感染檢測市場的成長受到多種因素的共同驅動，包括臨床需求、技術進步、人口趨勢和不斷發展的醫療保健服務。其中一個關鍵促進因素是全球尿道結石的上升，尤其是在持續成長的患者群體中，包括女性、老年人以及患有慢性疾病和留置導尿管的患者。同時，人們越來越意識到未經治療的尿道結石（例如腎臟感染、敗血症和慢性復發）的風險，這促使人們更早、更頻繁地進行檢測。抗生素抗藥性的加速發展也促使人們在開立抗生素處方前進行更準確的診斷，鼓勵醫療保健提供者採用快速的病原體特異性檢測。分子和數位技術的作用日益增強，再加上價格實惠的即時檢測套組和家用檢測套組的日益普及，正在擴大診斷範圍並減少獲取障礙。有利的法律規範、支持性的報銷政策以及促進感染疾病監測的公共衛生舉措，正在為檢測創新和市場成長創造有利環境。此外，遠端醫療、行動診斷和診斷即服務 (DaaS) 平台的興起，正在擴大尿道結石檢測服務涵蓋偏遠地區和服務欠缺人群的範圍。隨著這些趨勢的不斷發展，在臨床緊迫性、患者賦能和診斷創新等共同驅動下，尿道感染檢測市場有望實現強勁且持續的成長。

部分

類型（尿道炎、膀胱炎、腎盂腎炎）；最終用途（全科醫生、泌尿系統、泌尿系統、醫院實驗室、參考實驗室、醫院急診科、急診護理、其他）

受訪公司範例

  • Accelerate Diagnostics, Inc.
  • Acutis Diagnostics
  • Becton, Dickinson and Company（BD）
  • Beckman Coulter
  • bioMerieux
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin
  • F. Hoffmann-La Roche Ltd.
  • GENETWORx
  • Healthy.io
  • Patients Choice Laboratories
  • QIAGEN
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • T2 Biosystems, Inc.
  • TestCard
  • Thermo Fisher Scientific, Inc.
  • Uritest Medical
  • Winx

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP33210

Global Urinary Tract Infection Testing Market to Reach US$723.7 Million by 2030

The global market for Urinary Tract Infection Testing estimated at US$612.5 Million in the year 2024, is expected to reach US$723.7 Million by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Urethritis, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$390.0 Million by the end of the analysis period. Growth in the Cystitis segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$166.9 Million While China is Forecast to Grow at 5.2% CAGR

The Urinary Tract Infection Testing market in the U.S. is estimated at US$166.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$139.6 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Urinary Tract Infection (UTI) Testing Market - Key Trends & Drivers Summarized

Is the Rising Global Burden of UTIs Fueling a Surge in Diagnostic Demand?

Urinary tract infections (UTIs) are among the most common bacterial infections globally, impacting hundreds of millions of people annually and leading to a substantial increase in diagnostic testing. The growing incidence of UTIs across all age groups-particularly among women, the elderly, and individuals with diabetes, kidney conditions, or immunocompromised states-is driving sustained demand for rapid and accurate testing solutions. As awareness of early diagnosis and antimicrobial stewardship increases, healthcare systems are investing more in point-of-care diagnostics to reduce the burden on hospitals and minimize the overprescription of antibiotics. Recurrent and complicated UTIs, often associated with catheter use or structural abnormalities in the urinary tract, further contribute to the growing volume of diagnostic procedures in both inpatient and outpatient settings. Additionally, the global rise in healthcare-acquired infections (HAIs), particularly in long-term care facilities, is heightening the need for reliable UTI screening protocols. As clinicians aim to differentiate between asymptomatic bacteriuria and true infection, demand is shifting toward more specific and sensitive tests that can accurately guide treatment decisions. This evolving clinical landscape is pushing diagnostic laboratories, primary care providers, and urgent care centers to expand their capabilities in UTI detection, driving growth in the global UTI testing market.

How Are Technological Advancements and POC Diagnostics Transforming UTI Testing?

Technological innovation is dramatically reshaping the urinary tract infection testing landscape, with a growing emphasis on speed, accuracy, and accessibility. Traditional culture-based methods, though highly reliable, require 24-48 hours for results and are gradually being supplemented or replaced by rapid diagnostics. Modern urine dipstick tests and urinalysis kits now offer quicker detection of nitrites, leukocyte esterase, and other key indicators of infection, making them valuable tools in emergency departments and primary care settings. Additionally, molecular diagnostics-particularly PCR-based tests-are enabling the rapid identification of specific pathogens and resistance genes, significantly improving the precision of diagnosis and supporting appropriate antibiotic prescribing. Point-of-care (POC) platforms are becoming increasingly popular due to their portability, user-friendliness, and ability to deliver real-time results, particularly in rural or resource-limited environments. Automated urine analyzers are also being integrated into clinical laboratories to streamline workflows, reduce manual error, and allow for high-throughput testing. Furthermore, smartphone-connected devices and AI-driven diagnostic tools are emerging as novel solutions for home-based UTI monitoring, especially for patients with chronic or recurrent infections. These technological advancements are not only optimizing diagnostic accuracy but also helping clinicians move toward evidence-based, individualized treatment strategies, ultimately reducing the burden of antibiotic resistance and recurrent infections.

Are Shifting Healthcare Models and Consumer Behaviors Expanding the Market for UTI Testing?

As healthcare systems evolve toward decentralized, patient-centered care, urinary tract infection testing is increasingly being conducted in non-traditional settings such as retail clinics, home testing environments, and telehealth-driven diagnostic platforms. Consumers today demand convenience, speed, and confidentiality-especially for sensitive conditions like UTIs. This has led to the proliferation of at-home UTI test kits, which can be purchased over the counter or online, offering privacy and rapid self-screening. These kits often utilize colorimetric strip technologies or app-connected sensors that help users interpret results accurately and decide when to seek medical attention. Telemedicine providers have also embraced UTI testing as a high-demand service, often prescribing antibiotics based on symptoms and test confirmations without the need for an in-person visit. Additionally, employers and universities are offering UTI screening services as part of occupational health and wellness programs, further expanding testing beyond traditional clinical environments. On the institutional side, the emphasis on early detection and infection control in hospitals, nursing homes, and rehabilitation centers is driving routine screening and post-catheterization monitoring. This expansion of care settings-alongside greater patient involvement in health management-is fostering a dynamic and rapidly diversifying market for UTI testing, encouraging the development of new test formats and distribution models to meet this demand.

What Is Driving the Global Growth of the Urinary Tract Infection Testing Market?

The growth in the urinary tract infection testing market is driven by multiple converging factors tied to clinical need, technological progress, demographic trends, and healthcare delivery evolution. A major driver is the global increase in UTI prevalence, particularly among women, the elderly, and individuals with chronic illnesses or indwelling catheters, all of whom represent a consistent and expanding patient base. In parallel, rising awareness around the dangers of untreated UTIs-such as kidney infections, sepsis, and chronic recurrence-is prompting earlier and more frequent testing. The acceleration of antimicrobial resistance is also encouraging more precise diagnosis before antibiotic prescription, pushing healthcare providers to adopt rapid and pathogen-specific tests. The growing role of molecular and digital technologies, combined with the increased availability of affordable point-of-care and home-based test kits, is enhancing diagnostic reach and reducing access barriers. Favorable regulatory frameworks, supportive reimbursement policies, and public health initiatives promoting infectious disease surveillance are creating an enabling environment for testing innovation and market growth. Furthermore, the rise of telehealth, mobile diagnostics, and diagnostic-as-a-service (DaaS) platforms is expanding the availability of UTI testing to remote and underserved populations. As these trends continue to evolve, the urinary tract infection testing market is poised for strong and sustained expansion, driven by the combined imperatives of clinical urgency, patient empowerment, and diagnostic innovation.

SCOPE OF STUDY:

The report analyzes the Urinary Tract Infection Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Urethritis, Cystitis, Pyelonephritis); End-Use (General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories, Hospital Emergency Departments, Urgent Care, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Accelerate Diagnostics, Inc.
  • Acutis Diagnostics
  • Becton, Dickinson and Company (BD)
  • Beckman Coulter
  • bioMerieux
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin
  • F. Hoffmann-La Roche Ltd.
  • GENETWORx
  • Healthy.io
  • Patients Choice Laboratories
  • QIAGEN
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • T2 Biosystems, Inc.
  • TestCard
  • Thermo Fisher Scientific, Inc.
  • Uritest Medical
  • Winx

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Urinary Tract Infection Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising UTI Prevalence Among Aging and At-Risk Populations Spurs Global Testing Demand
    • Growth in Recurrent and Complicated UTI Cases Strengthens Business Case for Rapid and Accurate Diagnostics
    • Increased Awareness and De-Stigmatization of Urinary Health Expands Addressable Market Opportunity
    • Shift Toward Point-of-Care and Home Testing Solutions Drives Adoption in Non-Clinical Settings
    • Technological Advancements in Molecular Diagnostics Propel Innovation in UTI Test Accuracy and Speed
    • Expansion of Telehealth Platforms Throws the Spotlight on Remote UTI Diagnosis and Testing Integration
    • Widespread Antibiotic Resistance Crisis Accelerates Demand for Pathogen-Specific UTI Testing
    • Consumer Preference for Privacy and Convenience Generates Growth in Over-the-Counter UTI Test Kits
    • Incorporation of AI and Digital Health Tools Enhances Decision Support and Test Interpretation Accuracy
    • Rising Healthcare-Associated UTI Incidence in Hospitals and Long-Term Care Sustains Demand for Surveillance Testing
    • Availability of UTI Testing Through Online Pharmacies and E-Commerce Channels Expands Patient Access
    • Integration of UTI Testing into Preventive and Women's Health Programs Creates New Growth Avenues
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Urinary Tract Infection Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Urinary Tract Infection Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Urethritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Urethritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Urethritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cystitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cystitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cystitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pyelonephritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pyelonephritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Pyelonephritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Urgent Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Urgent Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Urgent Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for General Practitioners by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for General Practitioners by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for General Practitioners by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Urologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Urologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Urologists by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Urogynecologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Urogynecologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Urogynecologists by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Hospital Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospital Emergency Departments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospital Emergency Departments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospital Emergency Departments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • JAPAN
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • CHINA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • EUROPE
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Urinary Tract Infection Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • FRANCE
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • GERMANY
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Spain 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Spain 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Russia 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Russia 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Urinary Tract Infection Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Australia 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Australia 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • INDIA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 128: India Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: India 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 131: India Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: India 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: South Korea 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: South Korea 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Urinary Tract Infection Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Latin America 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Argentina 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Argentina 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Brazil 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Brazil 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Mexico 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Mexico 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Urinary Tract Infection Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Middle East 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Iran 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Iran 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Israel 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Israel 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: UAE 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: UAE 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • AFRICA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Africa 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Africa 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030

IV. COMPETITION